Exelixis, Inc. (EXEL)

Exelixis, Inc. achieves an elite AlphaScore of 90/100 in the Healthcare sector as of October 11, 2026. The company features an exceptional gross margin of 96.39% and a high return on equity of 36.21%. A major strength is its outstanding profitability, highlighted by top-tier gross and net margins. A risk is the moderate valuation sensitivity given a P/E ratio of 18.59. Evidence is limited to the supplied record.

Written 11/10/2026, 00:43:41 UTC · Snapshot 11/10/2026